Managing Breast Cancer Treatment: Dyad's Perspectives on Treatment Decision, Financial and Family Burden.
NCT ID: NCT05917444
Last Updated: 2023-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
224 participants
OBSERVATIONAL
2023-04-12
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment
NCT03817814
A Multicenter Prospective Observational Cohort Based on a Breast Cancer Medical Record Database in China
NCT06591039
Characteristics and Treatment Trends of Young Breast Cancer in China
NCT05068115
Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer
NCT00713141
A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China
NCT02493569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Patients with newly diagnosed or recurrent breast cancer who require chemotherapy or targeted immunotherapy as recommended by their physicians
2. Age 20 to 70
3. Within 0.5 to 3 years of newly diagnosed or recurrent breast cancer
4. Ability to perform housework or wage employment before cancer
5. Those whose cognitive function is sufficient to read newspaper news and answer questionnaires
* breast cancer family
1. Patient has been 0.5 to 3 years since the first diagnosis or recurrence of breast cancer and the doctor recommends chemotherapy or targeted immunotherapy
2. Patient's self-reported family members who are involved in the patient's physical, social, or medical caregivers with cancer
3. Age 20 to 65
4. Able to perform housework or wage workers
5. Those whose cognitive function is sufficient to read newspaper news and answer questionnaires
Exclusion Criteria
1. Patients who were disabled before suffering from cancer
2. only undergoing surgery or hormone therapy
* breast cancer family
1. Persons with physical, mental and social disabilities
2. Family members who are not involved in the patient's physical, social, or medical care for cancer
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Taipei University of Nursing and Health Sciences
OTHER
National Taiwan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yen-Shen Lu
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital
Shiuyu C. LEe
Role: PRINCIPAL_INVESTIGATOR
National Taipei University of Nursing and Health Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Taiwan University Hospital
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202301195RINB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.